Biomet M2A Magnum Hip Implant: FDA Stance

Few hip replacement surgeries were performed on those younger than sixty in the past under the belief that older patients were less active therefore would place less stress and strain on an artificial hip joint. Hip implants were initially constructed of polyethylene or ceramic, however manufacturers began constructing the implants out of cobalt and chromium under the belief they would hold up much longer than the polyethylene or ceramic implants. The past ten years have seen more physicians considering hip replacement surgery in younger patients, particularly those who suffer from such diseases as rheumatoid arthritis or those who have undergone bone tumors, fractures or serious hip injuries. The goal of hip replacement surgery is to provide a lessening of pain, a quality-of-life improvement and increased range of motion.

The FDA Approval of the Biomet M2A Magnum

The Biomet M2A Magnum all-metal hip implant received FDA approval under the controversial 510(k) process in 2004. Complaints for the M2A Magnum (and all metal-on-metal hip implants) began surfacing soon after they began being routinely implanted in patients—sometime in 2006. Zimmer, Inc. recalled their all-metal hip implant in 2008, and two years later DePuy recalled their ASR all-metal hip implant systems. Just this year Stryker recalled its Rejuvenate and ABGII metal—on-metal hip implants.

Most of the adverse reports received by the FDA eventually resulted in early device failures which led to expensive and potentially dangerous revision surgery. In fact, revision surgeries for all-metal hip implants totaled over 14,000. Although the all-metal hip implants were believed to have a life expectancy of fifteen or more years, the estimates—depending on the specific device—range from 7.5% to as high as 50% failure rate. The FDA can only order a Post-Market study of these all-metal hip implants for three years, meaning devices which last slightly longer than three years will not be reported as being ineffective or having failed.

If You Have Experienced Difficulties with Your Biomet M2A Magnum

Even if you have not yet experienced difficulties with your Biomet M2A Magnum implant you could well find yourself having problems later on. Those recipients of the M2A who have failed to consult an attorney and join in the litigation against Biomet may find they are in a difficult financial and medical position. Each recipient of the Biomet M2A Magnum should have a thorough understanding of the potential risks and symptoms of failure. Many elderly patients may actually be suffering chronic and severe pain, inflammation and difficulty with mobility yet are unaware of the potential risks of the M2A so chalk their symptoms up to advanced age. Although the FDA has not yet mandated a recall of the Biomet M2A Magnum, recipients of the device should consult their physician as well as an experienced attorney who can offer solid information regarding the dangers of the Biomet M2A Magnum.

Call the highly experienced attorneys of Sullo & Sullo today and get the information you need in order to make an informed decision about pursuing a claim.

Free Consultation  Call Now

Get Interactive

Sullo & Sullo-Facebook Sullo & Sullo-Linkedin Sullo & Sullo-Twitter Sullo & Sullo-You Tube
Free Consultation
Receive an immediate response to your request.
Choose the Practice Area of Your Problem:

I understand and agree that submitting this form does not create an attorney-client relationship and that the information I submit is not confidential or privileged and may be shared. I further understand and agree to the Terms of Use and Privacy Policy

Enter the code shown above in the box below

Recent Articles & Publications

July 15, 2015
July 14, 2015 - Understanding the Biomet M2A Magnum Hip Settlement Agreement - In January, 2014, a Biomet M2A Magnum hip settlement agreement was reached for those who had...

July 1, 2015
July 1, 2015 - In January, 2014, Biomet agreed to a $56 million settlement which would resolve lawsuits for all those who received a hip implant and later suffered Biomet M2A Magnum hip failure, requiring revisions surgery. Each qualified plaintiff was set to receive a base payment of $200,000, although individual plaintiffs would see deductions and additions to that amount, depending on their circumstances. If you received a Biomet M2A Magnum device, it could......

June 23, 2015
June 22, 2015 - Biomet M2A Magnum Hip Dangers - If you were implanted with a Biomet M2A Magnum hip device and have experienced problems associated with the implant, you may...